![Fotis Sakellaridis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fotis Sakellaridis
Vorstandsvorsitzender bei Qualia Pharma
Vermögen: 42 Mio $ am 30.06.2024
Profil
Fotis Sakellaridis is currently the Chief Executive Officer at Qualia Pharma.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
IDNA GENOMICS PUBLIC LTD
52,00% | 21.04.2023 | 1 435 373 ( 52,00% ) | 42 Mio $ | 30.06.2024 |
Aktive Positionen von Fotis Sakellaridis
Unternehmen | Position | Beginn |
---|---|---|
Qualia Pharma
![]() Qualia Pharma Pharmaceuticals: MajorHealth Technology Qualia Pharma manufactures pharmaceuticals products. It specializes in nutraceuticals and medcal devices. The company was founded in 2009 and is headquartered in Attiki, Greece. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Qualia Pharma
![]() Qualia Pharma Pharmaceuticals: MajorHealth Technology Qualia Pharma manufactures pharmaceuticals products. It specializes in nutraceuticals and medcal devices. The company was founded in 2009 and is headquartered in Attiki, Greece. | Health Technology |